Back to top
more

Amarin (AMRN)

(Delayed Data from NSDQ)

$16.03 USD

16.03
87,086

+0.26 (1.65%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $15.97 -0.06 (-0.37%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (156 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Amarin (AMRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

by Zacks Equity Research

After losing some value lately, a hammer chart pattern has been formed for Amarin (AMRN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Zacks Equity Research

Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Amarin (AMRN) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.

Zacks Equity Research

Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises

by Zacks Equity Research

AMRN beats second-quarter estimates for earnings. Revenues rise year over year on strong licensing gains.

Zacks Equity Research

Amarin Gears Up to Report Q2 Earnings: Here's What to Expect

by Zacks Equity Research

AMRN braces up for second-quarter results as U.S. Vascepa sales are likely to slide, while growth in the EU looks imminent.

Zacks Equity Research

VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales

by Zacks Equity Research

Shares of Viking slide after Q2 loss widens to 58 cents per share on rising R&D and nil revenues, missing estimates by 14 cents.

Zacks Equity Research

Are Medical Stocks Lagging DexCom (DXCM) This Year?

by Zacks Equity Research

Here is how DexCom (DXCM) and Amarin (AMRN) have performed compared to their sector so far this year.

Zacks Equity Research

Zacks.com featured highlights include Mama's Creations, Bassett Furniture Industries and Amarin

by Zacks Equity Research

MAMA, BSET, and AMRN are breakout stocks to watch, each boasting double-digit earnings growth potential in 2025.

Tirthankar Chakraborty headshot

3 Strong Buy Breakout Stocks for Explosive Returns

by Tirthankar Chakraborty

MAMA, BSET and AMRN meet breakout criteria with strong earnings growth and prices near 52-week highs.

Abhinab Dasgupta headshot

Take the Zacks Approach to Beat the Markets: Amarin, Mogo, 3M in Focus

by Abhinab Dasgupta

Zacks' model upgrades drove major gains for Amarin, Mogo and 3M, even as broader markets wobbled on tariff fears.

Zacks Equity Research

FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill

by Zacks Equity Research

MRK's regulatory filing for once-daily HIV pill DOR/ISL gets FDA acceptance, with a decision expected by April 2026.